subsidiary for Quarter 1 of 2019 ending on 31 March 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st
suppliers. The plant now has been completed but still in the process of mechanical testing and improving the treatment formula. For the RDF facility in the second quarter, the Company has started to adjust
Q2/2019 ∆% Q1/2020 ∆% Revenues from sales of medical equipment and services 431,618 440,596 -2% 301,848 43% Revenues from sales and beauty treatment services 3,568 43,985 -92% 22,202 -84% Interest
perform duties or provide services honestly and a wrongful treatment of investor assets in contravention of the governing Notification of the Capital Market Supervisory Board. The SEC therefore revoked his
Civil Court (Undecided Case No. 2374/2562 and Decided Case No. 6984/2563). The Court of Appeal’s decision is final.SEC Secretary-General Ruenvadee Suwanmongkol said: “This is a case of unfair treatment
Development (OECD), which cover six areas as follows: 1. Enforcement and CG framework 2. Rights of shareholders 3. Equitable treatment of shareholders 4. Roles of stakeholders in CG 5. Disclosure and
treatment income of chronic diseases from Social Security Office. Subsequently, Mr. Kumpol Plussind commit offense in using Mr. Krit Plussind's and Miss Kullapa Plussind's securities trading
Microsoft Word - MD&A_E Q1_2561_จัดใหม่ Management Discussion and Analysis: MD&A 1. Company Situation Revenue from the waste treatment business for Q1/2018 slightly increased compare to Q1/2017. The
Company and its subsidiary for Quarter 3 of 2019 ending on 30 September 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical